Cancer Genetics, Inc.

CGI is an emerging leader in DNA-based cancer diagnostics and services some of the most prestigious medical institutions in the world. Our tests target cancers that are difficult to diagnose and predict treatment outcomes. These cancers include hematological, urogenital and HPV-associated cancers. We provide a range of non-proprietary oncology-focused tests and laboratory services. CGI's proprietary tests and reference laboratory provide critical genomic information to healthcare professionals as well as biopharma and biotech. Our reference lab is focused entirely on maintaining clinical excellence and is both CLIA certified and CAP accredited and has licensure from several states. The company was founded in 1999 by world-renowned cytogeneticist Dr. Chaganti; and has since built on a foundation of world-class scientific knowledge and IP in solid and blood-borne cancers, while also establishing strong research collaborations with Memorial Sloan-Kettering, The Cleveland Clinic, and NCI.